.hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

Recombinant KexII Protease API GMP Grade for Precision Protein Processing & Biopharma

Recombinant KexII Protease GMP Enzyme for Biopharmaceutical Manufacturing

Recombinant KexII Protease represents a cutting-edge enzymatic solution for precision processing in biopharmaceutical manufacturing. As a calcium-dependent serine protease belonging to the subtilisin family, KexII specifically recognizes and cleaves at paired basic residues (KR- and RR- sites), making it indispensable for the activation of pro-proteins and maturation of recombinant therapeutic peptides. Our recombinant version, produced through advanced microbial expression systems, delivers superior purity, consistency, and activity compared to traditional native preparations, ensuring reliable performance in critical bioprocessing applications.

Manufactured under stringent cGMP conditions with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our Recombinant KexII Protease guarantees exceptional quality and safety profiles. The enzyme demonstrates remarkable specificity for dibasic cleavage sites while maintaining minimal non-specific proteolytic activity, making it ideal for processing sensitive biopharmaceutical products where precise cleavage is paramount. Through rigorous quality control measures including mass spectrometry, peptide mapping, and functional activity assays, we ensure each batch meets the highest standards for pharmaceutical applications.

The global biopharmaceutical market’s rapid expansion, particularly in peptide-based therapeutics and recombinant protein drugs, has created significant demand for high-quality processing enzymes like KexII Protease. Our enzyme is specifically optimized for critical applications including pro-insulin conversion, monoclonal antibody processing, and the activation of various recombinant therapeutic proteins. With its robust performance across diverse pH and temperature conditions, and excellent stability in various buffer systems, our Recombinant KexII Protease enables manufacturers to achieve higher yields, improved product quality, and reduced production costs. Backed by comprehensive technical support and flexible packaging options, we provide biopharmaceutical partners with reliable enzymatic solutions that drive innovation and maintain competitive advantage in global markets.